Target intelligence / Profile preview

Septin filament complex (SEPT)

Target
SEPT
Molecular classification
Cytoskeletal protein, GTP-binding protein, Scaffold protein, GTPase
01

Overview

Septin filament complexes are highly conserved GTP-binding proteins that assemble into non-polar filaments, rings, and gauzes, representing the fourth component of the cytoskeleton alongside actin, microtubules, and intermediate filaments (Mostowy & Cossart, 2012, Nature Reviews Molecular Cell Biology). They function as molecular scaffolds for protein recruitment and as diffusion barriers that compartmentalize membranes, playing essential roles in cytokinesis, cell polarity, and vesicle trafficking (Spiliotis, 2018, Journal of Cell Science). In clinical oncology, septins like SEPT9 are significant; its DNA methylation is a validated biomarker for the early detection of colorectal cancer (Song & Li, 2017, Medical Science Monitor). Furthermore, dysregulated septin expression is associated with neurodegenerative diseases, such as Alzheimer's and Parkinson's, where they are found in pathological protein aggregates (Zhai et al., 2020, Frontiers in Cell and Developmental Biology). While specific clinical drugs targeting septins are currently limited, small molecules like forchlorfenuron (FCF) are used in research to disrupt septin dynamics, demonstrating their potential as targets for anti-proliferative and anti-metastatic therapies.

Other names
SeptinsSEPT proteinsCytoskeletal septinsGTP-binding proteinsSeptin oligomers
02

Mechanism of action

Disruption of septin filament assembly and stabilization of septin-GTP binding to inhibit cytokinesis and scaffold-dependent signaling pathways (Hu et al., 2008, JBC).

03

Biological functions

CytokinesisCell cycleCell polarityMembrane remodelingScaffoldingCiliogenesisVesicle traffickingDiffusion barrier formation
04

Disease associations

CancerNeurodegenerative diseaseInfectionInfertilityNeuropathic pain
05

Safety considerations

Potential systemic toxicity due to inhibition of cytokinesis in healthy proliferating cellsHigh structural homology between the 13 human septin isoforms leading to lack of therapeutic specificityComplex assembly dynamics making targeted disruption difficult without affecting essential cellular architecture
06

Interacting drugs

Forchlorfenuron
07

Biomarkers

SEPT9 DNA methylationSEPT7 expression levelsSEPT2 overexpressionSEPT11 expression

Beyond the preview

Go deeper on Septin filament complex (SEPT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Septin filament complex (SEPT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call